Pacritinib in CMML

NCT06159491 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myelomonocytic Leukemia

Interventions

DRUG: Pacritinib
DRUG: Azacitidine

Sponsor

Douglas Tremblay

Collaborators

[object Object]